Risperdal and Weight loss - a phase IV clinical study of FDA data
Weight loss is found among people who take Risperdal, especially for people who are male, 10-19 old, have been taking the drug for 2 - 5 years.
The phase IV clinical study analyzes which people take Risperdal and have Weight loss. It is created by eHealthMe based on reports of 116,048 people who have side effects when taking Risperdal from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
116,048 people reported to have side effects when taking Risperdal.
Among them, 4,379 people (3.77%) have Weight loss.
What is Risperdal?
Risperdal has active ingredients of risperidone. It is often used in bipolar disorder. eHealthMe is studying from 117,497 Risperdal users for its effectiveness, alternative drugs and more.
What is Weight loss?
Weight loss is found to be associated with 2,607 drugs and 2,114 conditions by eHealthMe.
Number of Risperdal and Weight loss reports submitted per year:
Time on Risperdal when people have Weight loss *:
Gender of people who have Weight loss when taking Risperdal*:
Age of people who have Weight loss when taking Risperdal *:
Common drugs people take besides Risperdal *:
Common side effects people have besides Weight loss *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Risperdal and have Weight loss?Check whether Weight loss is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Janardhana P, Nagaraj AK, Basavanna PL, "Risperidone-induced skin rash", Indian journal of psychiatry, 2016 Jan .
- Dsouza MC, "Could risperidone have caused the cataract?: A case report and review of literature", Journal of Research in Psychiatry and Behavioral Science, 2015 Jan .
- Dsouza MC, "COULD RISPERIDONE HAVE CAUSED THE CATARACT", JRPBS, 2015 Jan .
- Ray RK, Bashir MA, Rao S, "Co-Administration of Risperidone and Sodium Valproate Causing Bilateral Chronic Exertional Lower Leg Compartment Syndrome", Open Journal of Orthopedics, 2014 Apr .
- Hosseini, S. H., & Ahmadi, A., "Peripheral edema occurring during treatment with risperidone combined with citalopram", Case reports in medicine, 2012 Jan .
Alternative drugs to, pros and cons of Risperdal:
- Risperdal (117,497 reports)
Weight loss treatments and more:
- Weight loss (46,517 reports)
COVID vaccines that are related to Weight loss:
- Weight loss in Moderna COVID Vaccine
- Weight loss in Pfizer BioNTech Covid Vaccine
- Weight loss in Johnson and Johnson Covid Vaccine
How severe was Weight loss and when was it recovered:
Expand to all the drugs that have ingredients of risperidone:
- Weight loss and drugs with ingredients of risperidone (4,756 reports)
Common drugs associated with Weight loss:
All the drugs that are associated with Weight loss:
- Weight loss (2,607 drugs)
Common conditions associated with Weight loss:
All the conditions that are associated with Weight loss:
- Weight loss (2,114 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on risperidone (the active ingredients of Risperdal) and Risperdal (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Temaz and Neutropenic Sepsis - a second ago
- Xanax and Systemic Lupus Erythematosus - 4 seconds ago
- Temaz and Social Avoidant Behavior - 6 seconds ago
- Tricor and Balance Disorder - 7 seconds ago
- Lopressor and Dysfunctional Uterine Bleeding (Dub) - 8 seconds ago